161 related articles for article (PubMed ID: 38285597)
1. High-dimensional in situ proteomics imaging to assess γδ T cells in spatial biology.
Herold N; Bruhns M; Babaei S; Spreuer J; Castagna A; Yurttas C; Scheuermann S; Seitz C; Ruf B; Königsrainer A; Jurmeister P; Löffler MW; Claassen M; Wistuba-Hamprecht K
J Leukoc Biol; 2024 Mar; 115(4):750-759. PubMed ID: 38285597
[TBL] [Abstract][Full Text] [Related]
2. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
Li Y; Li G; Zhang J; Wu X; Chen X
Front Immunol; 2020; 11():619954. PubMed ID: 33664732
[TBL] [Abstract][Full Text] [Related]
3. γδ T Cells in Tumor Microenvironment.
Imbert C; Olive D
Adv Exp Med Biol; 2020; 1273():91-104. PubMed ID: 33119877
[TBL] [Abstract][Full Text] [Related]
4. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
[TBL] [Abstract][Full Text] [Related]
5. Differences in circulating γδ T cells in patients with primary colon cancer and relation with prognostic factors.
Andreu-Ballester JC; Galindo-Regal L; Hidalgo-Coloma J; Cuéllar C; García-Ballesteros C; Hurtado C; Uribe N; Del Carmen Martín M; Jiménez AI; López-Chuliá F; Llombart-Cussac A
PLoS One; 2020; 15(12):e0243545. PubMed ID: 33326443
[TBL] [Abstract][Full Text] [Related]
6. Deciphering human γδ T cell response in cancer: Lessons from tumor-infiltrating γδ T cells.
Lo Presti E; Dieli F; Fourniè JJ; Meraviglia S
Immunol Rev; 2020 Nov; 298(1):153-164. PubMed ID: 32691450
[TBL] [Abstract][Full Text] [Related]
7. Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity.
Lopes N; Silva-Santos B
Eur J Immunol; 2021 Jan; 51(1):17-26. PubMed ID: 33188652
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic avenues for γδ T cells in cancer.
Costa GP; Mensurado S; Silva-Santos B
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38007241
[TBL] [Abstract][Full Text] [Related]
9. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments.
Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L
Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452
[TBL] [Abstract][Full Text] [Related]
10. Tumor resistance mechanisms and their consequences on γδ T cell activation.
Wesch D; Kabelitz D; Oberg HH
Immunol Rev; 2020 Nov; 298(1):84-98. PubMed ID: 33048357
[TBL] [Abstract][Full Text] [Related]
11. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
12. γδ T Cell Update: Adaptate Orchestrators of Immune Surveillance.
Hayday AC
J Immunol; 2019 Jul; 203(2):311-320. PubMed ID: 31285310
[TBL] [Abstract][Full Text] [Related]
13. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
Ma R; Yuan D; Guo Y; Yan R; Li K
Front Immunol; 2020; 11():1600. PubMed ID: 33013819
[TBL] [Abstract][Full Text] [Related]
14. Human Peripheral Blood Gamma Delta T Cells: Report on a Series of Healthy Caucasian Portuguese Adults and Comprehensive Review of the Literature.
Fonseca S; Pereira V; Lau C; Teixeira MDA; Bini-Antunes M; Lima M
Cells; 2020 Mar; 9(3):. PubMed ID: 32188103
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic CD69
Bruni E; Cimino MM; Donadon M; Carriero R; Terzoli S; Piazza R; Ravens S; Prinz I; Cazzetta V; Marzano P; Kunderfranco P; Peano C; Soldani C; Franceschini B; Colombo FS; Garlanda C; Mantovani A; Torzilli G; Mikulak J; Mavilio D
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35863820
[TBL] [Abstract][Full Text] [Related]
16. Multiomics profiling reveals the benefits of gamma-delta (γδ) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
Li J; Cao Y; Liu Y; Yu L; Zhang Z; Wang X; Bai H; Zhang Y; Liu S; Gao M; Lu C; Li C; Guan Y; Tao Z; Wu Z; Chen J; Yuan Z
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38199610
[TBL] [Abstract][Full Text] [Related]
17. A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR.
Deseke M; Rampoldi F; Sandrock I; Borst E; Böning H; Ssebyatika GL; Jürgens C; Plückebaum N; Beck M; Hassan A; Tan L; Demera A; Janssen A; Steinberger P; Koenecke C; Viejo-Borbolla A; Messerle M; Krey T; Prinz I
J Exp Med; 2022 Sep; 219(9):. PubMed ID: 35852466
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing of human breast tumour-infiltrating immune cells reveals a γδ T-cell subtype associated with good clinical outcome.
Boufea K; González-Huici V; Lindberg M; Symeonides S; Oikonomidou O; Batada NN
Life Sci Alliance; 2021 Jan; 4(1):. PubMed ID: 33268347
[TBL] [Abstract][Full Text] [Related]
19. Gut γδ T cells as guardians, disruptors, and instigators of cancer.
Suzuki T; Hayman L; Kilbey A; Edwards J; Coffelt SB
Immunol Rev; 2020 Nov; 298(1):198-217. PubMed ID: 32840001
[TBL] [Abstract][Full Text] [Related]
20. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
Reyes RM; Deng Y; Zhang D; Ji N; Mukherjee N; Wheeler K; Gupta HB; Padron AS; Kancharla A; Zhang C; Garcia M; Kornepati AVR; Boyman O; Conejo-Garcia JR; Svatek RS; Curiel TJ
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
